Research programme: atopic dermatitis therapeutics- Phytopharm

Drug Profile

Research programme: atopic dermatitis therapeutics- Phytopharm

Alternative Names: P 55

Latest Information Update: 24 Apr 2007

Price : $50

At a glance

  • Originator Phytopharm
  • Class
  • Mechanism of Action Interleukin 4 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Atopic dermatitis

Most Recent Events

  • 07 Oct 2003 This programme is still in active development
  • 29 Jan 2002 Preclinical development for Atopic dermatitis in United Kingdom (Topical)
  • 03 May 1999 Phase-I clinical trials for Atopic dermatitis in United Kingdom (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top